National League MVP Shohei Ohtani, American League MVP Aaron Judge and four other award winners from last year will wear a special gold Major League Baseball logo patch for the 2025 season, MLB has ...

Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable of reaching targets beyond the liver. The Japanese drugmaker is best ...

On March 11, 2025, we remember the profound loss and resilience of the people of Japan following the Great East Japan Earthquake and the Fukushima Daiichi nuclear disaster. Fourteen years later ...

Some MAGA world allies are speaking out in disgust over UFC President Dana White’s chummy Friday meetup with social media personality and self-described misogynist Andrew Tate, who has been ...

A few days later, The New York Times published a much-discussed behind-the-scenes report on the latest gathering of the White House Cabinet, which focused considerable attention on the secretary ...

Warner Bros. Television is promoting from within. Clancy Collins White, who has been with the studio for more than 20 years, is adding to her portfolio after she was promoted to President ...

J.P. Morgan analyst Seiji Wakao maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) on March 5 and set a price target of Yen4,600.00. The company’s shares closed ...

Snow White, Disney’s next major release, will not be receiving a UK premiere in London (Picture: Disney) It was reported that bosses had declined to hold a glitzy premiere in London, as would be ...

After years of speculation, Dana White has entered the boxing game. White is set to be a part of the executive leadership of a new boxing promotion that is a partnership between Turki Alalshikh ...

AstraZeneca and Daiichi Sankyo also recently won the FDA’s approval for another ADC they are working on together. Datroway, which also carries a topoisomerase I inhibitor but instead targets the TROP2 ...

AstraZeneca and Daiichi Sankyo's Enhertu has become the first HER2-directed drug to mount a patient survival benefit in a randomized clinical trial in second-line metastatic stomach cancer ...

Cambridge: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with ...